Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2009
03/11/2009EP1581526B1 Benzisoxazole derivatives useful as inhibitors of protein kinases
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/11/2009EP1317445B1 Chemokine receptor binding heterocyclic compounds
03/11/2009EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk)
03/11/2009CN101384585A Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
03/11/2009CN101384583A Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
03/11/2009CN101384582A Piperazine compounds useful as antagonists of C-C chemokines (CCR2B and CCR5) for the treatment of inflammatory diseases
03/11/2009CN101384581A Benzoyl-piperidine derivatives as 5HT2/D3 modulators
03/11/2009CN101384565A Substituted oxadiazole derivatives and their use as opioid receptor ligands
03/11/2009CN101384563A Substituted oxazole derivatives with an analgesic action
03/11/2009CN101384559A Benzimidazole derivatives and their use for modulating the GABA-A receptor complex
03/11/2009CN101384558A Gaba-b receptor modulators
03/11/2009CN101381366A Benzimidazole derivative and its use as a ii receptor antagonist
03/11/2009CN101381365A Dual action antibiotics
03/11/2009CN101381345A Tetrahydroquinoline derivatives and a process for preparing the same
03/11/2009CN100467466C Intermediate products for producing oxazolidinone-quinolone hybrids
03/11/2009CN100467465C Functionalized picolinic acid double dentate anion ligand and its annular metal iridium complex and uses
03/11/2009CN100467456C Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
03/11/2009CN100467023C Use of N-(3-methoxy-5-methyl pyrazine-2-group)-2-(4-[1,3,4-oxadiazole-2-group]phenyl) pyridine-3-sulfanilamide as anticarcinogen
03/10/2009US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
03/10/2009US7501427 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer
03/10/2009US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009US7501416 Quinoxaline compounds and methods of using them
03/10/2009US7501414 Substituted morpholine and thiomorpholine derivatives
03/10/2009US7501413 Dicarboxamide derivatives
03/10/2009US7501408 2-(R)-Cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-4-thiomorpholin-4-yl-butyramide; selective in presence of at least one other cathepsin isozyme; antiinflammatory agent: arthritis, atherosclerosis
03/10/2009US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens
03/10/2009US7501406 4-chloro-N-((R)-5,5-difluoro-2-oxo-azepan-3-yl)-N-[2-fluoro-4-(2H-[1,2,4]triazol-3-yl)-benzyl]-benzenesulfonamide; gamma -secretase inhibitor; neurodegenerative diseases; Alzheimer's disease; anticarcinogenic agent; cervical carcinomas and breast carcinomas and malignancies of the hematotic system
03/05/2009WO2009029617A1 Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors
03/05/2009WO2009028543A1 Substituted pyrazole derivative
03/05/2009WO2009028280A1 Pyrazolecarboxylic acid derivative, method for producing the same and bactericide
03/05/2009WO2009027746A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
03/05/2009WO2009027475A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
03/05/2009WO2009027395A1 A new class of histone deacetylase inhibitors
03/05/2009WO2009027392A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
03/05/2009WO2009026858A1 Derivatives of acridinone as anti-parasitic, anti-fungal and anti-viral agents
03/05/2009WO2009026658A1 Ppar agonists
03/05/2009WO2009026621A1 Pharmaceutical compound & composition
03/05/2009WO2009012242A3 Sodium channel inhibitors
03/05/2009WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use
03/05/2009WO2009007747A3 Hydantoin derivatives used as mmp12 inhibitors
03/05/2009WO2009005677A3 Antiviral compounds
03/05/2009WO2008147812A3 4' substituted compounds having 5-ht6 receptor affinity
03/05/2009WO2008145681A3 Ccr2 receptor antagonists and uses thereof
03/05/2009WO2008138591A3 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
03/05/2009WO2008138448A3 Heterocyclic indazole derivatives
03/05/2009WO2008070447A3 Anti-viral compounds
03/05/2009US20090062534 Linezolid crystalline hydrate form and linezolid salts
03/05/2009US20090062533 5-hydroxy-7H-benzo[C]fluorene derivatives: 7,7-dimethyl-5-hydroxy-9-morpholino-7H-benzo[C]fluorene; intermediates for preparing indeno-fused naphthopyrans exhibiting reversible photochromism
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062358 Peroxisome proliferator activated receptor alpha agonists
03/05/2009US20090062356 Substituted benzimidazole derivatives
03/05/2009US20090062349 1-Hydroxycycloalkanecarboxamide derivatives
03/05/2009US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
03/05/2009US20090062297 Hydroxyalkylarylamide Derivatives
03/05/2009US20090062293 1,4-Substituted Piperazine Derivatives
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090062283 Deuterium-enriched linezolid
03/05/2009US20090062282 Substituted Amino-Pyrimidones and Uses Thereof
03/05/2009US20090062281 such as 7-(2-[1,4']Bipiperidinyl-1'-yl-ethoxy)-6-methoxy-4-(4-phenoxy-phenylamino)-quinoline-3-carbonitrile, useful in the prevention of diseases associated with the Ras/Raf/MEK signaling cascade in a mammals, such as tumors, cancer, strokes, osteoporosis, arthritis and inflammatory diseases
03/05/2009US20090062280 Ophthalmic Compositions for Treating Ocular Hypertension
03/05/2009US20090062279 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
03/05/2009US20090062278 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
03/05/2009US20090062277 Phosphodiesterase 10 inhibitors
03/05/2009US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
03/05/2009US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS
03/05/2009US20090062266 7-methoxy-2-methyl-N-[[(5S)-[3-[3-fluoro-4-(piperazin-1-yl)phenyl]-2-oxo-5-oxazolidinylmethyl]-3-quinolinecarboxamide, useful for the treatment of grampositive and some gramnegative bacterial infections, with a weak monoamine oxidase inhibitory activity
03/05/2009US20090062261 Nitrogen-containing heterocycle derivatives substituted with cyclic group
03/05/2009US20090062252 Therapeutic isoxazole compounds
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/05/2009US20090061141 Monomethine dye compound, optical information recording medium utilizing the compound and process for producing the same
03/05/2009US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use
03/05/2009US20090060874 Bicyclic pyrrolidine derivatives
03/05/2009CA2697663A1 Substituted pyrazole derivative
03/05/2009CA2697382A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
03/05/2009CA2696767A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
03/05/2009CA2696609A1 Therapeutic isoxazole compounds
03/04/2009EP2030981A1 Compounds for proteasome enzyme inhibition
03/04/2009EP2030970A1 Allosteric modulators of metabotropic glutamate receptors
03/04/2009EP2029576A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/04/2009EP2029575A1 Substituted spirocyclic cgrp receptor antagonists
03/04/2009EP2029561A1 Tricyclic compound and pharmaceutical use thereof
03/04/2009EP2029560A2 1,3-oxazolidin-2-one derivatives useeful as cetp inhibitors
03/04/2009EP2029559A1 Aryl-4-ethynyl-isoxazole derivatives
03/04/2009EP2029543A2 Substituted 3-cyanopyridines as protein kinase inhibitors
03/04/2009EP1833795B1 Pyridine compounds for the treatment of prostaglandin mediated diseases
03/04/2009EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent
03/04/2009EP1551812B1 Mitotic kinesin inhibitors
03/04/2009EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase
03/04/2009EP1427720B1 3-substituted-4-pyrimidone derivatives
03/04/2009EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity
03/04/2009EP0869974B1 Compounds with growth hormone releasing properties
03/04/2009CN101379048A Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
03/04/2009CN101379044A Heterobicyclic sulfonamide derivatives for the treatment of diabetes
03/04/2009CN101379033A Secondary amines
03/04/2009CN101378756A Piperidine derivatives as CXCR3 receptor antagonists
03/04/2009CN101376655A Penicillazine derivative, and preparation and use thereof